New treatments for disease, healthier food products and faster pathways from laboratory research to real-world health solutions are one step closer for Ulster University's Coleraine’s Centre for Food and Drug Discovery (CFDD), following the signing of the funding agreement enabling the next phase of the flagship innovation project.

Funded through the Causeway Coast and Glens Growth Deal, the Centre will bring together leading expertise in pharmaceutical sciences, biomedical research and food innovation, working in partnership with industry to address pressing health challenges and improve health outcomes.

Through cutting-edge research and industry collaboration, CFDD will accelerate the discovery, development and commercialisation of new medicines, functional foods and health technologies, making innovation faster, more efficient and affordable.

The signing of the funding agreement is a key milestone for the project, marking the transition from planning to delivery. The centre forms part of the wider Causeway Coast and Glens Growth Deal, an investment between the UK Government and local governments to drive inclusive and sustainable economic growth across the region.

This investment will purchase specialist equipment to provide a one-stop- shop service for industry partners to develop and test products at all stages in the innovation pipeline. The centre has collaborated with key stakeholders including industry, clinicians and researchers to identify the challenges they are facing and to close the gap with their in-house research and development capacity.

The team within the CFDD are already producing real world impact, having carried out robust trials on insomnia, anxiety and weight management devices for Neurovalens, a Belfast based health tech company. The projects included clinical trials and regulatory evidence generation that contributed to Food and Drug Administration (FDA) approvals to launch its products in the US and created new global market opportunities.

The Centre has an established relationship with the Almac Group and has been awarded a prestigious grant from the Academy of Medical Sciences to collaborate with them on a project exploring innovative ways to manufacture medicines that are more easily absorbed by the body, helping to improve the effectiveness of treatments and deliver better outcomes for patients.

As well as delivering benefits for public health, CFDD will strengthen Northern Ireland's life and health sciences sector by attracting investment, supporting business innovation, creating high-value jobs and developing the skills pipeline needed for future economic growth.

Ulster University Vice-Chancellor Professor Paul Bartholomew said:

" At Ulster University, we play a vital role in bringing together researchers, industry, clinicians and policymakers to create the conditions in which innovation can thrive. Through partnerships such as this, we are strengthening Northern Ireland's life and health sciences ecosystem and ensuring that world-leading research can deliver tangible benefits for society and have impact on a global scale.

“The CFDD will help bridge the gap between scientific discovery and real-world application through accelerating innovation, reducing barriers to product development, and supporting the delivery of new solutions that improve public health outcomes.

“This impact will be felt across Northern Ireland by attracting investment, creating high value jobs, and creating opportunities for businesses, researchers and students to contribute to innovations that improve lives.

“The signing of the CFDD funding agreement unlocks the next phase of the project, enabling work to progress and turning a shared vision for regional growth and opportunity into tangible action.”

Mayor of Causeway Coast and Glens Borough Council, Councillor Dawn Huggins commented:

"This is an important milestone for Causeway Coast and Glens and demonstrates the real potential of the Growth Deal to deliver lasting benefits for our Borough. Ulster University’s Centre for Food and Drug Discovery will put our area at the forefront of exciting developments in pharmaceutical sciences, food innovation and health research.

“By bringing together world-class expertise and industry, this project has the potential to support new discoveries, create opportunities for collaboration and contribute to better health outcomes for people locally and further afield.

“As Mayor, I am delighted to see this investment progressing and look forward to seeing the positive impact it will have on our local economy, our communities and the future of innovation in Causeway Coast and Glens.”

Welcoming the signing of the funding agreement, Economy Minister Dr Caoimhe Archibald said:

“This project offers a tremendous opportunity to grow the life and health sciences sector. It will provide businesses with access to specialist equipment and research expertise to develop, test and commercialise new products—helping firms overcome barriers to innovation, compete in global markets and pursue new opportunities for growth.

“Building on significant investments already made in the north’s life and health sciences sector, it can help attract further investment and support the creation of high-value jobs. By connecting business growth with the development of specialist skills, the project can strengthen the sector and create lasting economic opportunities across the north.”

Design and enabling works will now progress and as the project moves toward delivery the team will continue to engage closely with industry partners. It welcomes companies of all sizes, from SME’s to large corporations, to get in touch to discover how the centre can address their challenges, unlock new opportunities and drive business growth.